Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 51 entries
View as:

Switch Strategy From Etravirine (ETR) to Doravirine (DOR) in Virologically-Suppressed HIV-1 Infected Adults With ETR-Resistance

Phase: N/A Priority: Normal
NCT ID: NCT05506605 Org: User:
Start: 12/12/22 End: 12/31/24 Due: 12/31/25

Regorafenib Followed by Nivolumab in Patients With Hepatocellular Carcinoma (GOING)

Phase: N/A Priority: Normal
NCT ID: NCT04170556 Org: User:
Start: 03/16/20 End: 07/09/24 Due: 07/09/25

Airway Management With Supraglottic Devices in Unruptured Intracranial Aneurysms

Phase: N/A Priority: Normal
NCT ID: NCT03632902 Org: User:
Start: 06/26/18 End: 11/20/19 Due: 11/20/20

First in Human Study of the Infusion of ARI0003 Cells in Relapsed/Refractory to Treatment B-cell Aggressive Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT06097455 Org: User:
Start: 01/15/24 End: 01/15/27 Due: 01/15/28

Randomized Controlled Trial to Assess the Effects of Sapropterin on Hepatic and Systemic Hemodynamics in Patients With Liver Cirrhosis and Portal Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01456286 Org: User:
Start: 10/31/11 End: 10/31/13 Due: 10/31/14

Antibody-mediated LGI1 Encephalitis: Symptoms, Biomarkers, and Mechanisms of the Chronic Phase of the Disease

Phase: N/A Priority: Normal
NCT ID: NCT06515106 Org: User:
Start: 12/18/23 End: 12/31/26 Due: 12/31/27

2-(1-{6-[(2-[F-18]Fluoroethyl) (Methyl)Amino]-2-naphthyl} Ethylidene) Malononitrile-PET for in Vivo Diagnose of Tauopathy in Unclassified Parkinsonism

Phase: N/A Priority: Normal
NCT ID: NCT02214862 Org: User:
Start: 03/31/13 End: 02/29/16 Due: 02/28/17

Plasma Exchange in Patients With COVID-19 Disease and Invasive Mechanical Ventilation: a Randomized Controlled Trial

Phase: N/A Priority: Normal
NCT ID: NCT04374539 Org: User:
Start: 04/29/20 End: 06/29/21 Due: 06/29/22

Comparison of Two Combinations in Antiretroviral Post-Exposure Prophylaxis for HIV-1: Tenofovir/Emtricitabine (Truvada ®) + Lopinavir/Ritonavir (Kaletra ®) vs Tenofovir/Emtricitabine/Cobicistat/Elvitegravir (Stribild ®). Prospective, Randomized, Open.

Phase: N/A Priority: Normal
NCT ID: NCT02198443 Org: User:
Start: 06/06/15 End: - Due: -

Assessment of the Impact of Type of Probiotic, Delivery Type and Feeding Type on Baby's Microbiota After Dysbiotic Delivery

Phase: N/A Priority: Normal
NCT ID: NCT04304014 Org: User:
Start: 03/05/20 End: 11/30/24 Due: 11/30/25

Regenerative Medicine in Ocular Surface: Application of Cell Therapy for Ocular Surface Repair Using Progenitor Cells of Sclerocorneal Limbus Amplified ex Vivo

Phase: N/A Priority: Normal
NCT ID: NCT01470573 Org: User:
Start: 11/30/11 End: 12/31/12 Due: 12/31/13

Trial Testing the Effect of Strategies on Performance of Brief Intervention Programmes for Harmful Alcohol Consumption

Phase: N/A Priority: Normal
NCT ID: NCT01501552 Org: User:
Start: 01/31/12 End: 12/31/14 Due: 12/31/15

Efficacy of GZR/EBR in Early Chronic Hepatitis C in HIV/HCV Co-infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT02897596 Org: User:
Start: 04/28/17 End: 10/30/19 Due: 10/30/20

Evaluation of the Therapeutic Usability of RESPIRA ADVANCED Device in Patients Under Invasive Mechanical Ventilation

Phase: N/A Priority: Normal
NCT ID: NCT05174130 Org: User:
Start: 05/01/22 End: 03/31/23 Due: 03/31/24

Antibiotic or Not in Non-purulent Exacerbations of COPD: a Trial of Security and Efficacy

Phase: N/A Priority: Normal
NCT ID: NCT01091493 Org: User:
Start: 07/31/10 End: 07/05/18 Due: 07/05/19

Pilot Study Evaluate Efficacy of Grazoprevir + Elbasvir for 12 or 16 Weeks in Liver Transplant Recipients.

Phase: N/A Priority: Normal
NCT ID: NCT02890719 Org: User:
Start: 08/03/16 End: 06/01/17 Due: 06/01/18

Study to Evaluate the Safety and Efficacy of ARI0002h, for the Initial Treatment of Patients With Primary Plasma Cell Leukaemia

Phase: N/A Priority: Normal
NCT ID: NCT06830733 Org: User:
Start: 04/30/25 End: 12/31/27 Due: 12/31/28

Diagnostic of Human Immunodeficiency Virus (HIV) and Other Sexual Transmission Diseases (STD) in High Risk Populations: Men Who Have Sex With Men (MSM) Users of Chemsex

Phase: N/A Priority: Normal
NCT ID: NCT03546140 Org: User:
Start: 06/30/18 End: 06/30/21 Due: 06/30/22

Effects on the Awakening With Laryngeal Mask vs Endotracheal Tube in Endoscopic Endonasal Transsphenoidal Base Surgery

Phase: N/A Priority: Normal
NCT ID: NCT02988804 Org: User:
Start: 01/20/17 End: 12/05/19 Due: 12/05/20

Evaluation of the Impact of a Multidimensional ICT Intervention on the Quality of Life of Breast Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT05401643 Org: User:
Start: 11/01/20 End: 06/30/23 Due: 06/30/24

Continuous Renal Replacement Therapy Doses in Critically Ill Patients with Acute Kidney Injury

Phase: N/A Priority: Normal
NCT ID: NCT06901011 Org: User:
Start: 04/01/25 End: 08/31/27 Due: 08/31/28

Probiotics and the Neurodevelopment in the Premature Infant <32 Weeks Gestational Age and <1500g

Phase: N/A Priority: Normal
NCT ID: NCT05945017 Org: User:
Start: 01/01/14 End: 12/31/27 Due: 12/31/28

Sentinel Node Detection With Technetium-99m Albumin Nanocolloid and ICG in Patients With Epithelial Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05937620 Org: User:
Start: 11/30/23 End: 10/31/26 Due: 10/31/27

Subjects With Subjective Cognitive Decline: 18F-Florbetaben Positron Emission Tomography Study

Phase: N/A Priority: Normal
NCT ID: NCT03057938 Org: User:
Start: 07/31/20 End: 06/30/22 Due: 06/30/23

Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Protein SOSIP v8.2 763 Vaccine, Adjuvanted With MPLA Liposomes, in Healthy, HIV-Uninfected Adults

Phase: N/A Priority: Normal
NCT ID: NCT05772286 Org: User:
Start: 07/24/23 End: 06/30/25 Due: 06/30/26